5.2872 USD
+0.08 (+1.48%)
Taking everything into account, HIND scores 2 out of 10 in our fundamental rating. HIND was compared to 188 industry peers in the Health Care Equipment & Supplies industry. HIND scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HIND does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
HIND had negative earnings in the past year.
In the past year HIND has reported a negative cash flow from operations.
HIND had negative earnings in each of the past 5 years.
In the past 5 years HIND always reported negative operating cash flow.
1.2 Ratios
HIND has a worse Return On Assets (-49.82%) than 67.55% of its industry peers.
HIND's Return On Equity of -77.17% is in line compared to the rest of the industry. HIND outperforms 40.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.82% | ||
| ROE | -77.17% | ||
| ROIC | N/A |
ROA(3y)-223.45%
ROA(5y)-181.34%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of HIND (62.59%) is better than 63.30% of its industry peers.
In the last couple of years the Gross Margin of HIND has grown nicely.
The Profit Margin and Operating Margin are not available for HIND so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.59% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y44.4%
2. Health
2.1 Basic Checks
HIND does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HIND has more shares outstanding
Compared to 5 years ago, HIND has more shares outstanding
Compared to 1 year ago, HIND has a worse debt to assets ratio.
2.2 Solvency
HIND has an Altman-Z score of -95.31. This is a bad value and indicates that HIND is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -95.31, HIND is doing worse than 95.21% of the companies in the same industry.
HIND has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -95.31 |
ROIC/WACCN/A
WACC8.61%
2.3 Liquidity
HIND has a Current Ratio of 2.77. This indicates that HIND is financially healthy and has no problem in meeting its short term obligations.
HIND has a Current ratio of 2.77. This is comparable to the rest of the industry: HIND outperforms 53.19% of its industry peers.
HIND has a Quick Ratio of 1.97. This is a normal value and indicates that HIND is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.97, HIND is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.77 | ||
| Quick Ratio | 1.97 |
3. Growth
3.1 Past
HIND shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.40%, which is quite impressive.
HIND shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.86%.
HIND shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.54% yearly.
EPS 1Y (TTM)93.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.55%
Revenue 1Y (TTM)-19.86%
Revenue growth 3Y-16.19%
Revenue growth 5Y19.54%
Sales Q2Q%-36.79%
3.2 Future
Based on estimates for the next years, HIND will show a very negative growth in Earnings Per Share. The EPS will decrease by -18.56% on average per year.
HIND is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -25.99% yearly.
EPS Next Y6.67%
EPS Next 2Y0%
EPS Next 3Y-18.56%
EPS Next 5YN/A
Revenue Next Year-97.51%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for HIND. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HIND. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as HIND's earnings are expected to decrease with -18.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0%
EPS Next 3Y-18.56%
5. Dividend
5.1 Amount
HIND does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:HIND (11/26/2025, 2:54:46 PM)
5.2872
+0.08 (+1.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.15%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner Change0%
Market Cap29.03M
Revenue(TTM)6.45M
Net Income(TTM)-4.50M
Analysts43.33
Price Target15.3 (189.38%)
Short Float %2.34%
Short Ratio0.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.5 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.98 | ||
| P/tB | 4.98 | ||
| EV/EBITDA | N/A |
EPS(TTM)-490.67
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-1.39
FCFYN/A
OCF(TTM)-1.39
OCFYN/A
SpS1.18
BVpS1.06
TBVpS1.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.82% | ||
| ROE | -77.17% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.59% | ||
| FCFM | N/A |
ROA(3y)-223.45%
ROA(5y)-181.34%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y44.4%
F-Score3
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.77 | ||
| Quick Ratio | 1.97 | ||
| Altman-Z | -95.31 |
F-Score3
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)11.32%
Cap/Depr(5y)20.35%
Cap/Sales(3y)0.55%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.55%
EPS Next Y6.67%
EPS Next 2Y0%
EPS Next 3Y-18.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.86%
Revenue growth 3Y-16.19%
Revenue growth 5Y19.54%
Sales Q2Q%-36.79%
Revenue Next Year-97.51%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A
EBIT growth 1Y32.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.6%
OCF growth 3YN/A
OCF growth 5YN/A
VYOME HOLDINGS INC / HIND FAQ
Can you provide the ChartMill fundamental rating for VYOME HOLDINGS INC?
ChartMill assigns a fundamental rating of 2 / 10 to HIND.
What is the valuation status for HIND stock?
ChartMill assigns a valuation rating of 0 / 10 to VYOME HOLDINGS INC (HIND). This can be considered as Overvalued.
What is the profitability of HIND stock?
VYOME HOLDINGS INC (HIND) has a profitability rating of 1 / 10.
What is the earnings growth outlook for VYOME HOLDINGS INC?
The Earnings per Share (EPS) of VYOME HOLDINGS INC (HIND) is expected to grow by 6.67% in the next year.